Moderna starts application for full US approval of Covid-19 vaccine
The development comes weeks after rival Pfizer Inc and its German partner BioNTech SE sought full approval for their Covid-19 vaccine in the United States
Coronavirus: On 16 November, 2020, US biotech company Moderna announced a vaccine against Covid-19 that is 94.5% effective. Montreal, 16 November, 2020/ Reuters
Moderna Inc said on Tuesday it has applied for full US approval of its Covid-19 vaccine, which is currently only authorized for emergency use in the country.
The development comes weeks after rival Pfizer Inc and its German partner BioNTech SE sought full approval for their Covid-19 vaccine in the United States.
